|
VeriChip Corporation
Pre-Announces 2007 Full-Year Revenue
Company’s revenues at the high-end of
its previously stated $30-32 million range, a year-over-year
increase of 17 percent
DELRAY BEACH, FL – January
15, 2008 – VeriChip Corporation (“VeriChip” or the “Company”)
(Nasdaq: CHIP), a provider of RFID systems for healthcare and
patient-related needs, announced today that it expects revenues for
2007 at the high-end of the Company's previously released guidance
of $30-32 million. During the fourth quarter of 2007, the Company
continued to experience strong sales of its healthcare security
products, specifically its infant protection and wander prevention
systems.
Scott R. Silverman, Chairman and Chief
Executive Officer of VeriChip, said, “I am very pleased with the
robust growth of our infant protection and wander prevention
systems. I am also proud of our focus on performance and delivering
results above expectations. Looking back at 2007, VeriChip met or
exceeded every qualitative and quantitative measure it established,
including the number of hospitals enrolled in our VeriMed™ Patient
Identification System and the number of protocol-adopted
facilities.”
About VeriChip
VeriChip Corporation, headquartered in
Delray Beach, Florida,
develops, markets and sells radio frequency identification, or RFID,
systems used to identify, locate and protect people and assets.
VeriChip's goal is to become the leading provider of RFID systems
for people in the healthcare industry. The Company recently began
marketing its VeriMed(TM) Patient Identification System,
a passive RFID system for rapidly and accurately identifying people
who arrive in an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID microchip, the
implantable VeriChip(TM), cleared for medical use in
October 2004 by the United States Food and Drug Administration.
For more information on VeriChip, please
call 1-800-970-2447, or email info@verichipcorp.com. Additional
information can be found online at
http://www.verichipcorp.com.
Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press
release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934, and as that term
is defined in the Private Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties and are
subject to change at any time, and the Company's actual results
could differ materially from expected results. The Company
undertakes no obligation to update forward-looking statements to
reflect subsequently occurring events or circumstances.
###
CONTACTS:
Dan Schustack
CEOcast
212-732-4300
Allison Tomek
VeriChip Corporation
(561) 805-8008
atomek@adsx.com
Back
|
